Page last updated: 2024-08-22

tiletamine hydrochloride and Graft-Versus-Host Disease

tiletamine hydrochloride has been researched along with Graft-Versus-Host Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, Y; Ikehara, S; Kaneko, K; Kuge, T; Li, M; Okigaki, M; Shimo, T; Takaya, J; Tsuji, S; Umezawa, K; Yamanouchi, S	1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and Graft-Versus-Host Disease

Article	Year
A nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation. Immunobiology, 2015, Volume: 220, Issue:9 Topics: Animals; Antibodies; Benzamides; Bone Marrow Transplantation; Cell Proliferation; Cyclohexanones; Cytokines; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Receptors, Cell Surface; Spleen; Survival Rate; T-Lymphocytes, Regulatory; Transplantation, Homologous	2015

Article

Year

A nuclear factor-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates GVHD in allogeneic bone marrow transplantation.

Immunobiology, 2015, Volume: 220, Issue:9

Topics: Animals; Antibodies; Benzamides; Bone Marrow Transplantation; Cell Proliferation; Cyclohexanones; Cytokines; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Receptors, Cell Surface; Spleen; Survival Rate; T-Lymphocytes, Regulatory; Transplantation, Homologous

2015